Latest News
Sanne Group sees strong performance continue in first half
Alternative asset and corporate administration services provider Sanne Group said its core business lines saw “good growth” in the first half of the year on Tuesday, driven by “strong momentum” from new business opportunities delivered in the latter part of 2016.
BBA Aviation swings to profit in first half
BBA Aviation said on Tuesday that it swung to a profit in the first half as it lifted its dividend by 5%.
BP moves back into the black, lowers cash break-evens
BP moved back into the black during the second quarter of 2017 thanks to an improved performance in its upstream arm with the firm having lowered its cash break-even level to $47 per barrel of oil.
Acquisition boosts Elementis in first half
Speciality chemicals company Elementis described a strong first half on Tuesday, with sales rising 24% year-on-year to $414. 8m and statutory profit ahead 16% at $43. 2m.
CYBG reports solid third quarter as it continues digital transformation
Clydesdale Bank and Yorkshire Bank owner CYBG made further progress towards its full-year guidance in the third quarter, it announced on Tuesday, with “solid” mortgage growth of 5. 8% annualised for the nine months to 30 June, and record volumes of applications in the quarter.
SFO opens bribery investigation into British American Tobacco
Britain's Serious Fraud Office has opened a formal investigation into possible historic bribery by British American Tobacco in Africa.
Man Group first-half FuM, profits rise
Man Group reported a rise in first-half funds under management and profit on Tuesday as net inflows and performance fees grew.
Meggitt organic profits fall as underlying orders remain depressed
Aerospace and defence engineer Meggitt reported a 6% fall in underlying profits for the first half of the year as orders declined before an expected rebound in the second half.
Europe open: Stocks start higher, buoyed by Chinese data
Stocks started the morning slightly higher, buoyed by a small dip in the single currency and despite a mixed close overnight on Wall Street.
Vantiv deadline to make formal bid for Worldpay extended
Payments processor Worldpay said on Tuesday that the deadline for US-based Vantiv to make a firm offer for the company has been extended to 8 August.
Trump sacks communications director Scaramucci after just 10 days
US President Donald Trump has sacked his communications director Anthony Scaramucci just 10 days after his appointment to the White House position.
Greggs sales up but profit drops on cost inflation
FTSE 250 baker Greggs reported a rise in first-half sales on Tuesday thanks to continued growth in its breakfast, coffee and ‘balanced choice’ ranges, although pre-tax profit declined on the back of cost inflation pressures.
Eurozone manufacturing growth remains strong though PMI dips
Manufacturing activity in the euro-area is growing slightly less than expected, according to fresh data published on Tuesday.
London open: Stocks in the black as investors digest earnings; Direct Line rallies
London stocks rose in early trade as investors chewed over more earnings reports and looked ahead to the latest survey on the UK manufacturing sector.
BGEO wins contract to upgrade Tbilisi metro ticketing system
BGEO Group announced on Tuesday that its banking business subsidiary, JSC Bank of Georgia, won an auction organised by Tbilisi City Hall for the modernisation of the public transportation payment system in Tbilisi, Georgia.
Land Securities exchanges pre-let agreement with Deutsche Bank
Land Securities and Deutsche Bank exchanged a pre-let agreement for the bank's new London headquarters at 21 Moorfields, EC2 on a 25-year lease, the companies announced on Tuesday, with the agreement conditional on planning permission.
Fresnillo reports on 'strong' first half
Fresnillo reported some solid numbers in its first half on Thursday, with adjusted revenue rising 11. 5% to $1. 07bn, while gross profit and EBITDA rose 16. 6% and 10. 2% respectively to $460m and $522. 5m.
FDA grants 'breakthrough therapy designation' to AstraZeneca for acalabrutinib
AstraZeneca and its haematology research and development "centre of excellence", Acerta Pharma, announced on Tuesday that the US Food and Drug Administration granted ‘breakthrough therapy designation’ for ‘acalabrutinib’, for the treatment of patients with mantle cell lymphoma (MCL) who have received at least one prior therapy.
Intertek posts solid first half numbers
Inspection, product testing and certification company Intertek described a first half of “strong” earnings growth and cash generation on Tuesday, with revenue improving 2. 7% and constant currencies and 13. 9% at actual rates to £1. 372bn.